FI62421C - Medel foer avhjaelpande av grumling i serum - Google Patents
Medel foer avhjaelpande av grumling i serum Download PDFInfo
- Publication number
- FI62421C FI62421C FI772812A FI772812A FI62421C FI 62421 C FI62421 C FI 62421C FI 772812 A FI772812 A FI 772812A FI 772812 A FI772812 A FI 772812A FI 62421 C FI62421 C FI 62421C
- Authority
- FI
- Finland
- Prior art keywords
- medium
- medium according
- serum
- oxide units
- ethylene oxide
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title claims description 22
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 239000008137 solubility enhancer Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 238000005375 photometry Methods 0.000 claims description 5
- 229920000151 polyglycol Polymers 0.000 claims description 5
- 239000010695 polyglycol Substances 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000002334 glycols Chemical class 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 150000005690 diesters Chemical class 0.000 claims description 2
- 150000002027 dodecanoic acid esters Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 238000007792 addition Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- -1 polyethylene Polymers 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 230000008033 biological extinction Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 5
- 239000012535 impurity Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 229960002645 boric acid Drugs 0.000 description 3
- 235000010338 boric acid Nutrition 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 2
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- BEVWMRQFVUOPJT-UHFFFAOYSA-N 2,4-dimethyl-1,3-thiazole-5-carboxamide Chemical compound CC1=NC(C)=C(C(N)=O)S1 BEVWMRQFVUOPJT-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 238000008114 Uric Acid Assay Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- GLZWNFNQMJAZGY-UHFFFAOYSA-N octaethylene glycol Chemical class OCCOCCOCCOCCOCCOCCOCCOCCO GLZWNFNQMJAZGY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2724757A DE2724757C2 (de) | 1977-06-01 | 1977-06-01 | Mittel zur Beseitigung von Trübungen in Serum und Verfahren zu seiner Herstellung |
| DE2724757 | 1977-06-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI772812A7 FI772812A7 (fi) | 1978-12-02 |
| FI62421B FI62421B (fi) | 1982-08-31 |
| FI62421C true FI62421C (fi) | 1982-12-10 |
Family
ID=6010423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI772812A FI62421C (fi) | 1977-06-01 | 1977-09-23 | Medel foer avhjaelpande av grumling i serum |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4184848A (en, 2012) |
| JP (1) | JPS53149390A (en, 2012) |
| AR (1) | AR212779A1 (en, 2012) |
| AT (1) | AT354641B (en, 2012) |
| BE (1) | BE858883A (en, 2012) |
| CA (1) | CA1121381A (en, 2012) |
| CH (1) | CH635437A5 (en, 2012) |
| DD (1) | DD131970A5 (en, 2012) |
| DE (1) | DE2724757C2 (en, 2012) |
| DK (1) | DK144668C (en, 2012) |
| FI (1) | FI62421C (en, 2012) |
| FR (1) | FR2393291A1 (en, 2012) |
| GB (1) | GB1542982A (en, 2012) |
| HU (1) | HU176755B (en, 2012) |
| IE (1) | IE45675B1 (en, 2012) |
| IL (1) | IL52986A (en, 2012) |
| IT (1) | IT1086033B (en, 2012) |
| NL (1) | NL172486C (en, 2012) |
| SE (1) | SE428474B (en, 2012) |
| SU (1) | SU791267A3 (en, 2012) |
| ZA (1) | ZA775815B (en, 2012) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2816229C2 (de) * | 1978-04-14 | 1983-11-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Mittel zur Beseitigung von Trübungen |
| DE2829531A1 (de) * | 1978-07-05 | 1980-01-24 | Heuck Claus Christian Dr Rer N | Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben |
| DE2839433A1 (de) * | 1978-09-11 | 1980-03-20 | Merck Patent Gmbh | Waessrige lipid-standardloesung und verfahren zu ihrer herstellung |
| ATE390T1 (de) * | 1978-11-01 | 1981-11-15 | Contraves Ag | Verfahren zur verminderung der stoerung einer photometrischen messung durch lichtstreuung in einer zu messenden suspension und reagenz zur durchfuehrung des verfahrens. |
| US4330622A (en) * | 1979-09-12 | 1982-05-18 | Becton Dickinson & Co. | Elimination of non-microbial turbidity in culture media |
| US4319882A (en) * | 1980-02-21 | 1982-03-16 | Yash Sharma | Method for detecting immunological agglutination and biochemical agent therefor |
| US4411795A (en) | 1980-03-10 | 1983-10-25 | Baxter Travenol Laboratories, Inc. | Particle adsorption |
| US4425427A (en) | 1980-03-13 | 1984-01-10 | Vitafin N.V. | Simultaneous, kinetic, spectrophotometric analysis of blood serum for multiple components |
| DE3021457A1 (de) * | 1980-06-06 | 1982-01-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und mittel zur aufloesung von chylomikronen in waessrigem mediums |
| CA1163908A (en) * | 1980-10-01 | 1984-03-20 | Shyun-Long Yun | Method for eliminating turbidity in a biological fluid and reagent therefor |
| DE3107060A1 (de) * | 1981-02-25 | 1982-09-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Kontroll- oder eichserum und verfahren zu seiner herstellung |
| US4506018A (en) * | 1982-12-30 | 1985-03-19 | Becton, Dickinson And Company | Blood diluent |
| JPS59162454A (ja) * | 1983-03-08 | 1984-09-13 | Kainosu:Kk | 体液中の濁りを除去する方法 |
| DE3323949A1 (de) * | 1983-07-02 | 1985-01-03 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit |
| JPS6247335U (en, 2012) * | 1985-09-09 | 1987-03-24 | ||
| FR2599149B1 (fr) * | 1986-05-21 | 1988-08-26 | Univ Nancy | Reactif pour la transparisation de milieux biologiques et ses applications analytiques. |
| DE3920364A1 (de) * | 1989-06-22 | 1991-01-10 | Technicon Gmbh | Verfahren und reagenz zur verhinderung von truebungen |
| JPH0395836U (en, 2012) * | 1990-01-19 | 1991-09-30 | ||
| DE19850074A1 (de) * | 1998-10-30 | 2000-05-04 | Dade Behring Marburg Gmbh | Stabilisierung von biologischen Flüssigkeiten durch Zusatz von Sterinestern |
| EP1233269B1 (en) * | 2001-02-19 | 2003-11-19 | Olympus Diagnostica GmbH | Agent for the removal of turbidity in biological samples |
| CN113203720B (zh) * | 2021-06-15 | 2022-09-06 | 山西农业大学 | 一种荧光分析法检测水产品中敌敌畏残留量的方法及检测试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3770631A (en) * | 1971-06-29 | 1973-11-06 | Baxter Laboratories Inc | Clarification of blood serum and plasma |
| US3853465A (en) * | 1972-06-09 | 1974-12-10 | Technicon Instr | Turbidity reduction in serum and plasma samples using polyoxyethylated lauric acid compounds |
| US3847482A (en) * | 1972-07-10 | 1974-11-12 | Bio Data Corp | Apparatus for detecting a change in turbidity of a solution |
| US3958939A (en) * | 1975-01-08 | 1976-05-25 | Coulter Electronics, Inc. | Method for clarification of lipemic serum |
| US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
-
1977
- 1977-06-01 DE DE2724757A patent/DE2724757C2/de not_active Expired
- 1977-08-24 AT AT612577A patent/AT354641B/de not_active IP Right Cessation
- 1977-08-31 AR AR269039A patent/AR212779A1/es active
- 1977-09-13 SU SU772532397A patent/SU791267A3/ru active
- 1977-09-16 GB GB38720/77A patent/GB1542982A/en not_active Expired
- 1977-09-20 IT IT27741/77A patent/IT1086033B/it active
- 1977-09-20 IE IE1916/77A patent/IE45675B1/en unknown
- 1977-09-20 BE BE181060A patent/BE858883A/xx not_active IP Right Cessation
- 1977-09-21 DD DD7700201144A patent/DD131970A5/xx unknown
- 1977-09-22 CA CA000287311A patent/CA1121381A/en not_active Expired
- 1977-09-22 CH CH1160277A patent/CH635437A5/de not_active IP Right Cessation
- 1977-09-22 SE SE7710630A patent/SE428474B/xx not_active IP Right Cessation
- 1977-09-23 US US05/836,111 patent/US4184848A/en not_active Expired - Lifetime
- 1977-09-23 DK DK422677A patent/DK144668C/da not_active IP Right Cessation
- 1977-09-23 FI FI772812A patent/FI62421C/fi not_active IP Right Cessation
- 1977-09-25 IL IL52986A patent/IL52986A/xx unknown
- 1977-09-27 HU HU77BO1683A patent/HU176755B/hu not_active IP Right Cessation
- 1977-09-28 FR FR7729173A patent/FR2393291A1/fr active Granted
- 1977-09-28 JP JP11655777A patent/JPS53149390A/ja active Granted
- 1977-09-29 ZA ZA00775815A patent/ZA775815B/xx unknown
-
1978
- 1978-01-02 NL NLAANVRAGE7800010,A patent/NL172486C/xx active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53149390A (en) | 1978-12-26 |
| FI62421B (fi) | 1982-08-31 |
| DK144668B (da) | 1982-05-03 |
| JPS5715340B2 (en, 2012) | 1982-03-30 |
| GB1542982A (en) | 1979-03-28 |
| SE428474B (sv) | 1983-07-04 |
| NL7800010A (nl) | 1978-12-05 |
| CH635437A5 (de) | 1983-03-31 |
| AT354641B (de) | 1979-01-25 |
| IE45675B1 (en) | 1982-10-20 |
| NL172486C (nl) | 1983-09-01 |
| SU791267A3 (ru) | 1980-12-23 |
| SE7710630L (sv) | 1978-12-02 |
| DK144668C (da) | 1982-10-04 |
| FR2393291A1 (fr) | 1978-12-29 |
| IL52986A (en) | 1980-03-31 |
| FI772812A7 (fi) | 1978-12-02 |
| ATA612577A (de) | 1979-06-15 |
| AR212779A1 (es) | 1978-09-29 |
| DD131970A5 (de) | 1978-08-09 |
| ZA775815B (en) | 1978-09-27 |
| IL52986A0 (en) | 1977-11-30 |
| IE45675L (en) | 1978-12-01 |
| DE2724757C2 (de) | 1979-08-23 |
| IT1086033B (it) | 1985-05-28 |
| DE2724757B1 (de) | 1978-12-21 |
| DK422677A (da) | 1978-12-02 |
| CA1121381A (en) | 1982-04-06 |
| FR2393291B1 (en, 2012) | 1980-08-01 |
| BE858883A (fr) | 1978-03-20 |
| US4184848A (en) | 1980-01-22 |
| HU176755B (en) | 1981-05-28 |
| AU2916277A (en) | 1978-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI62421C (fi) | Medel foer avhjaelpande av grumling i serum | |
| US5912139A (en) | Test strip | |
| Giegel et al. | Manual and semi-automated procedures for measurement of triglycerides in serum | |
| US5888827A (en) | Method for determination of cholesterol in low-density lipoprotein or very low-density lipoprotein | |
| JPS6345065B2 (en, 2012) | ||
| CN101061234B (zh) | 用于脂肪酶活性测定的组合物以及活性测定方法 | |
| AU2005227961B2 (en) | Method of multiquantification for cholesterol of low-density lipoprotein | |
| US20050287619A1 (en) | Method and reagent for measuring cholesterol in high-density lipoproteins | |
| CS219875B2 (en) | Method of fixing the triglycerine | |
| CA2614592A1 (en) | Method for stabilization of peptides in a biological sample | |
| JPH0476066B2 (en, 2012) | ||
| US5258315A (en) | Process and composition for the removal of turbidity from biological fluids | |
| KR20010108370A (ko) | 콜레스테롤의 정량법 | |
| JPH0151782B2 (en, 2012) | ||
| JP2003227798A (ja) | 試薬組成物の安定化方法及び安定化された試薬組成物 | |
| CN113308513A (zh) | 一种小而密低密度脂蛋白胆固醇检测试剂盒及其检测方法 | |
| JP4013108B2 (ja) | リパーゼの安定化方法 | |
| Juretić | The effect of phosphatidylcholine depletion on biochemical and physical properties of a Neurospora crassa membrane mutant | |
| Donceel et al. | The size and conformation of Artemia (brine-shrimp) ribosomal RNA free in solution | |
| JP2007174951A (ja) | リパーゼ活性測定用組成物および活性測定法 | |
| Ho et al. | The estimation of the activity of acetylcholinesterase and other esterases in the rat brain by an amperometric method | |
| Maker et al. | Microchemical assay of galactose containing cerebrosides | |
| JPH05123194A (ja) | リパーゼ活性測定用組成物及びその組成物を用いるリパーゼ活性測定方法 | |
| JPH0549279B2 (en, 2012) | ||
| Ohyama et al. | Sensitive densitometry for the determination of platelet-activating factor and other phospholipids in human tears |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: BOEHRINGER MANNHEIM GMBH |